Alyaa Al-Mughairy/LinkedIn
Jul 18, 2026, 15:31
Alyaa Al-Mughairy: Presenting Real-World Emicizumab Data at the ISTH 2026 Middle East Summit
Alyaa Al-Mughairy, Pediatric Hematology Oncology Senior Consultant at Ministry of Health Oman,and National Oncology Centre at Royal Hospital, shared a post on LinkedIn:
”I had the privilege of presenting our institutional, real-world experience with emicizumab in severe hemophilia A at the ISTH Middle East Summit standalone meeting in Paris, France.
Engaging in high-level discussions with colleagues from across the region was both inspiring and deeply enriching.
Even if the historic Paris heatwave meant our discussions weren’t the only things heating up!
It was a wonderful opportunity to connect, exchange insights, and collaborate.”
Stay updated with Hemostasis Today.
-
Jul 18, 2026, 18:00Karen Schreiber: Advancing Thrombosis Epidemiology Through Global Collaboration at ISTH 2026
-
Jul 18, 2026, 17:34Living With ITP – A New Resource for Navigating Your Diagnosis – ITP Support Association
-
Jul 18, 2026, 17:34Mona Alfaraj: It Was a Hot Week Attending ISTH 2026 Congress in Paris
-
Jul 18, 2026, 17:26Shernan Holtan: Latest Publication on PTCy
-
Jul 18, 2026, 17:20Doaa EL Demerdash: Connecting the Global ITP Community at ISTH 2026
-
Jul 18, 2026, 16:58Isabella Presch: Innovative Trial Designs for Rare Pediatric Studies
-
Jul 18, 2026, 16:36Caitlin Schneider: Research, Collaboration, and New Beginnings at ISTH 2026
-
Jul 18, 2026, 16:23Panagiota Tsiatsiou: Honored to Present Our Research at the ISTH 2026 Congress in Paris
-
Jul 18, 2026, 16:03Robert Tadevosyan: A Week of Science, Collaboration, and Growth at ISTH 2026